ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome

Xiangli Yang, Koichi Matsuda, Peter Bialek, Sylvie Jacquot, Howard C. Masuoka, Thorsten Schinke, Lingzhen Li, Stefano Brancorsini, Paolo Sassone-Corsi, Tim M. Townes, Andre Hanauer, Gerard Karsenty

Research output: Contribution to journalArticle

554 Citations (Scopus)

Abstract

Coffin-Lowry Syndrome (CLS) is an X-linked mental retardation condition associated with skeletal abnormalities. The gene mutated in CLS, RSK2, encodes a growth factor-regulated kinase. However, the cellular and molecular bases of the skeletal abnormalities associated with CLS remain unknown. Here, we show that RSK2 is required for osteoblast differentiation and function. We identify the transcription factor ATF4 as a critical substrate of RSK2 that is required for the timely onset of osteoblast differentiation, for terminal differentiation of osteoblasts, and for osteoblast-specific gene expression. Additionally, RSK2 and ATF4 posttranscriptionally regulate the synthesis of Type I collagen, the main constituent of the bone matrix. Accordingly, Atf4-deficiency results in delayed bone formation during embryonic development and low bone mass throughout postnatal life. These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.

Original languageEnglish (US)
Pages (from-to)387-398
Number of pages12
JournalCell
Volume117
Issue number3
DOIs
StatePublished - Apr 30 2004

Fingerprint

Coffin-Lowry Syndrome
Osteoblasts
Substrates
Bone
Activating Transcription Factor 4
X-Linked Mental Retardation
Phosphorylation
Bone Matrix
Collagen Type I
Osteogenesis
Gene expression
Embryonic Development
Intercellular Signaling Peptides and Proteins
Phosphotransferases
Genes
Phenotype
Gene Expression
Bone and Bones

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology : Implication for Coffin-Lowry syndrome. / Yang, Xiangli; Matsuda, Koichi; Bialek, Peter; Jacquot, Sylvie; Masuoka, Howard C.; Schinke, Thorsten; Li, Lingzhen; Brancorsini, Stefano; Sassone-Corsi, Paolo; Townes, Tim M.; Hanauer, Andre; Karsenty, Gerard.

In: Cell, Vol. 117, No. 3, 30.04.2004, p. 387-398.

Research output: Contribution to journalArticle

Yang, X, Matsuda, K, Bialek, P, Jacquot, S, Masuoka, HC, Schinke, T, Li, L, Brancorsini, S, Sassone-Corsi, P, Townes, TM, Hanauer, A & Karsenty, G 2004, 'ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome', Cell, vol. 117, no. 3, pp. 387-398. https://doi.org/10.1016/S0092-8674(04)00344-7
Yang, Xiangli ; Matsuda, Koichi ; Bialek, Peter ; Jacquot, Sylvie ; Masuoka, Howard C. ; Schinke, Thorsten ; Li, Lingzhen ; Brancorsini, Stefano ; Sassone-Corsi, Paolo ; Townes, Tim M. ; Hanauer, Andre ; Karsenty, Gerard. / ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology : Implication for Coffin-Lowry syndrome. In: Cell. 2004 ; Vol. 117, No. 3. pp. 387-398.
@article{0f1109371e584dea91663f841dad83f5,
title = "ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome",
abstract = "Coffin-Lowry Syndrome (CLS) is an X-linked mental retardation condition associated with skeletal abnormalities. The gene mutated in CLS, RSK2, encodes a growth factor-regulated kinase. However, the cellular and molecular bases of the skeletal abnormalities associated with CLS remain unknown. Here, we show that RSK2 is required for osteoblast differentiation and function. We identify the transcription factor ATF4 as a critical substrate of RSK2 that is required for the timely onset of osteoblast differentiation, for terminal differentiation of osteoblasts, and for osteoblast-specific gene expression. Additionally, RSK2 and ATF4 posttranscriptionally regulate the synthesis of Type I collagen, the main constituent of the bone matrix. Accordingly, Atf4-deficiency results in delayed bone formation during embryonic development and low bone mass throughout postnatal life. These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.",
author = "Xiangli Yang and Koichi Matsuda and Peter Bialek and Sylvie Jacquot and Masuoka, {Howard C.} and Thorsten Schinke and Lingzhen Li and Stefano Brancorsini and Paolo Sassone-Corsi and Townes, {Tim M.} and Andre Hanauer and Gerard Karsenty",
year = "2004",
month = "4",
day = "30",
doi = "10.1016/S0092-8674(04)00344-7",
language = "English (US)",
volume = "117",
pages = "387--398",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology

T2 - Implication for Coffin-Lowry syndrome

AU - Yang, Xiangli

AU - Matsuda, Koichi

AU - Bialek, Peter

AU - Jacquot, Sylvie

AU - Masuoka, Howard C.

AU - Schinke, Thorsten

AU - Li, Lingzhen

AU - Brancorsini, Stefano

AU - Sassone-Corsi, Paolo

AU - Townes, Tim M.

AU - Hanauer, Andre

AU - Karsenty, Gerard

PY - 2004/4/30

Y1 - 2004/4/30

N2 - Coffin-Lowry Syndrome (CLS) is an X-linked mental retardation condition associated with skeletal abnormalities. The gene mutated in CLS, RSK2, encodes a growth factor-regulated kinase. However, the cellular and molecular bases of the skeletal abnormalities associated with CLS remain unknown. Here, we show that RSK2 is required for osteoblast differentiation and function. We identify the transcription factor ATF4 as a critical substrate of RSK2 that is required for the timely onset of osteoblast differentiation, for terminal differentiation of osteoblasts, and for osteoblast-specific gene expression. Additionally, RSK2 and ATF4 posttranscriptionally regulate the synthesis of Type I collagen, the main constituent of the bone matrix. Accordingly, Atf4-deficiency results in delayed bone formation during embryonic development and low bone mass throughout postnatal life. These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.

AB - Coffin-Lowry Syndrome (CLS) is an X-linked mental retardation condition associated with skeletal abnormalities. The gene mutated in CLS, RSK2, encodes a growth factor-regulated kinase. However, the cellular and molecular bases of the skeletal abnormalities associated with CLS remain unknown. Here, we show that RSK2 is required for osteoblast differentiation and function. We identify the transcription factor ATF4 as a critical substrate of RSK2 that is required for the timely onset of osteoblast differentiation, for terminal differentiation of osteoblasts, and for osteoblast-specific gene expression. Additionally, RSK2 and ATF4 posttranscriptionally regulate the synthesis of Type I collagen, the main constituent of the bone matrix. Accordingly, Atf4-deficiency results in delayed bone formation during embryonic development and low bone mass throughout postnatal life. These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.

UR - http://www.scopus.com/inward/record.url?scp=11144357428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144357428&partnerID=8YFLogxK

U2 - 10.1016/S0092-8674(04)00344-7

DO - 10.1016/S0092-8674(04)00344-7

M3 - Article

C2 - 15109498

AN - SCOPUS:11144357428

VL - 117

SP - 387

EP - 398

JO - Cell

JF - Cell

SN - 0092-8674

IS - 3

ER -